These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38587919)
1. Super-enhancers: drivers of cells' identities and cells' debacles. Lavaud M; Tesfaye R; Lassous L; Brounais B; Baud'huin M; Verrecchia F; Lamoureux F; Georges S; Ory B Epigenomics; 2024 Apr; 16(9):681-700. PubMed ID: 38587919 [TBL] [Abstract][Full Text] [Related]
2. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer. Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532 [TBL] [Abstract][Full Text] [Related]
3. Targeting Super-Enhancers for Disease Treatment and Diagnosis. Shin HY Mol Cells; 2018 Jun; 41(6):506-514. PubMed ID: 29754476 [TBL] [Abstract][Full Text] [Related]
4. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers. Khan A; Mathelier A; Zhang X Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995 [TBL] [Abstract][Full Text] [Related]
5. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Whyte WA; Orlando DA; Hnisz D; Abraham BJ; Lin CY; Kagey MH; Rahl PB; Lee TI; Young RA Cell; 2013 Apr; 153(2):307-19. PubMed ID: 23582322 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Bacabac M; Xu W Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907 [TBL] [Abstract][Full Text] [Related]
7. The molecular understanding of super-enhancer dysregulation in cancer. Yoshino S; Suzuki HI Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935 [TBL] [Abstract][Full Text] [Related]
9. Super-enhancers in the control of cell identity and disease. Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843 [TBL] [Abstract][Full Text] [Related]
10. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?]. Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770 [TBL] [Abstract][Full Text] [Related]
11. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes. Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109 [TBL] [Abstract][Full Text] [Related]
12. Super-enhancers in transcriptional regulation and genome organization. Wang X; Cairns MJ; Yan J Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731 [TBL] [Abstract][Full Text] [Related]
13. From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions. Wu M; Shen J Front Oncol; 2019; 9():1307. PubMed ID: 31824865 [TBL] [Abstract][Full Text] [Related]